J&J said first-quarter revenues came in at $21.9 billion, up 2.4% on the same period of 2024, which was a little above analyst expectations.

J&J has set a list price of $12,480 per vial for its drug, saying that it is "competitively priced" compared to the other FcRn blockers, but hasn't yet revealed a launch date.

View the latest J&J Snack Foods Corp. (JJSF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Want to know why it's especially good? I've run into Cool Girl Chloë Sevigny shopping there not once, but twice. —Christian Allaire 3. Sincerely, Tommy 343 Tompkins Ave, Brooklyn, NY 11216 ...

A high-level overview of J&J Snack Foods Corp. (JJSF) stock. View (JJSF) real-time stock price, chart, news, analysis, analyst reviews and more.

SportsLine simulated the new NFL season 10,000 times and identified 2025 Fantasy football sleepers, breakouts and busts for upcoming drafts ...

Now, he'll have to adjust to a first-year starting quarterback in J.J. McCarthy, who'll make his NFL debut in 2025. Minnesota will likely have a more conservative offense this season, which limits ...